Is single-level cervical disc arthroplasty associated with a lower reoperation rate than anterior cervical discectomy and fusion?

作者
Alexander Tuchman,Yii‐Der Ida Chen,Corey T. Walker,Linda E.A. Kanim,Hyun W. Bae,David L. Skaggs
出处
期刊:Journal of neurosurgery [Journal of Neurosurgery Publishing Group]
卷期号:40 (3): 282-290 被引量:8
标识
DOI:10.3171/2023.10.spine23640
摘要

OBJECTIVE: Long-term meta-analysis of cervical disc arthroplasty (CDA) trials report lower rates of subsequent cervical spine surgical procedures with CDA compared with anterior cervical discectomy and fusion (ACDF). The objective of this study was to compare the rate of subsequent cervical spine surgery in single-level CDA-treated patients to that of a matched cohort of single-level ACDF-treated patients by using records from 2010 to 2021 included in a large national administrative claims database (PearlDiver). METHODS: This retrospective matched-cohort study used a large national insurance claims database; 525,510 patients who had undergone a single-level ACDF or CDA between 2010 and 2021 were identified. Patients with other same-day spine procedures, as well as those for trauma, infection, or tumor, were excluded, yielding 148,531 patients. ACDF patients were matched 2:1 to CDA patients on the basis of clinical and demographic characteristics. The primary outcome was the overall incidence of all-cause cervical reoperation after index surgery. Secondary outcomes included readmission, any adverse event within 90 days, and overall reintervention after index surgery. Multivariable logistic regression analyses were adjusted for covariates and were employed to estimate the effect of the index ACDF or CDA procedure on patient outcomes. Survival was assessed using Kaplan-Meier estimation, and differences between ACDF- and CDA-treated patients were compared using log-rank tests. RESULTS: After the patients were matched, 28,795 ACDF patients to 14,504 CDA patients were included. ACDF patients had higher rates of 90-day adverse events (18.4% vs 14.6%, adjusted odds ratio [aOR] 0.77, 95% CI 0.73-0.82, p < 0.001) and readmission (11.5% vs 9.7%, aOR 0.87, 95% CI 0.81-0.93, p < 0.001). Over a mean 4.3 years of follow-up, 5.0% of ACDF patients and 5.4% of CDA patients underwent reoperation (aOR 1.09, 95% CI 1.00-1.19, p = 0.059). The rate of aggregate reintervention was higher in CDA patients than in ACDF patients (11.7% vs 10.7%, aOR 1.10, p = 0.002). The Kaplan-Meier 10-year reoperation-free survival rate was worse for CDA than ACDF (91.0% vs 92.0%, p = 0.05), as was the rate of reintervention-free survival (81.2% vs 82.0%, p = 0.003). CONCLUSIONS: Single-level CDA was associated with a similar rate of reoperation and higher rate of subsequent injections when compared with a matched cohort that underwent single-level ACDF. CDA was associated with lower rates of 90-day adverse events and readmissions.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
chenzhaoyang发布了新的文献求助10
刚刚
香风智乃完成签到 ,获得积分10
刚刚
Ava的应助被大栗子采纳,获得10
刚刚
zhiguoxin完成签到,获得积分10
1秒前
chai完成签到,获得积分10
2秒前
blinkals57发布了新的文献求助10
2秒前
haan完成签到,获得积分10
3秒前
哈哈完成签到 ,获得积分10
3秒前
liu发布了新的文献求助10
4秒前
5秒前
lx1199完成签到 ,获得积分10
6秒前
zhu完成签到,获得积分10
6秒前
小小怪发布了新的文献求助30
6秒前
如小美完成签到,获得积分10
8秒前
迟书问剑完成签到 ,获得积分10
8秒前
Nothing发布了新的文献求助10
8秒前
9秒前
孤独星月发布了新的文献求助10
9秒前
请我吃葡萄完成签到 ,获得积分10
9秒前
Maestro_S的应助被Pupupapa采纳,获得10
9秒前
周江阔发布了新的文献求助10
9秒前
9秒前
10秒前
10秒前
直率万声发布了新的文献求助10
11秒前
11秒前
桐桐的应助被健康的魔镜采纳,获得10
12秒前
绿地土狗完成签到,获得积分10
12秒前
ding的应助被nikola采纳,获得10
13秒前
科研通AI6.4的应助被筑梦之鱼采纳,获得10
13秒前
wxwx发布了新的文献求助10
14秒前
加油完成签到 ,获得积分10
16秒前
16秒前
17秒前
17秒前
19秒前
qiqi发布了新的文献求助10
20秒前
20秒前
wanci的应助被小小怪采纳,获得10
20秒前
wangbw发布了新的文献求助10
20秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
Grapes 1000
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8178807
求助须知:如何正确求助?哪些是违规求助? 9569558
关于积分的说明 21805222
捐赠科研通 7773974
什么是DOI,文献DOI怎么找? 3432933
关于科研通互助平台的介绍 2556873
邀请新用户注册赠送积分活动 2478593